BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:http://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240329
DTSTAMP:20260516T003937
CREATED:20231107T111306Z
LAST-MODIFIED:20231107T111306Z
UID:38097-1711411200-1711670399@www.pharmajournalist.com
SUMMARY:5th Glioblastoma Drug Development Summit
DESCRIPTION:The 5th Glioblastoma Drug Development Summit is the only industry led forum for large pharma\, biotech\, neuro-oncologists and academic KOLs to unite alongside a dedicated panel of investors under the common goal to breakthrough GBM barriers to accelerate the practical translation and clinical development of emerging therapeutics for glioblastoma and CNS tumor patients. \nDiscover innovative approaches to surpassing the blood-brain barrier to unlock previously uncovered therapeutic potential\, keep ahead of the latest clinical trial design rationale and navigate the regulatory landscape for novel combination therapies with actionable insights to improve clinical success. \nWith promising clinical readouts from a range of therapeutic modalities\, novel drug targets emerging and positive advances in state-of-the-art technologies like sonodynamic therapy\, there is more potential than ever before to be unlocked within the GBM space. \nTo elevate your current standards\, join this unique collaboration between industry giants such as Novartis\, pioneering biotechs such as Day One Biopharmaceuticals\, world-renowned academics and investors. Embrace positive clinical outcomes alongside a dedicated community committed to defeating GBM/CNS tumors and transforming lives. \nAccess the complete agenda here including a packed pre-workshop conference day\, panel discussions\, poster sessions and important networking opportunities.
URL:http://www.pharmajournalist.com/event/5th-glioblastoma-drug-development-summit/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240326
DTEND;VALUE=DATE:20240330
DTSTAMP:20260516T003937
CREATED:20240103T114154Z
LAST-MODIFIED:20240103T114154Z
UID:38420-1711411200-1711756799@www.pharmajournalist.com
SUMMARY:7th Gene Therapy for Rare Disorders Summit
DESCRIPTION:This past year has seen more gene therapies approved by the FDA than the previous five years combined\, and almost triple the number of clinical trials in gene therapy have been initiated in H1 of 2023 compared to the same time frame in the previous year. \nTo maximize the value of your late-stage gene therapy assets\, the 7th Gene Therapy for Rare Disorders Summit is returning to tackle head-on the significant clinical\, manufacturing\, regulatory\, and commercial challenges facing gene therapy programs today. \nBringing together key figures from industry\, regulatory bodies\, patient non-profits\, payers\, and key service providers\, this is the field’s foremost meeting for collectively progressing rare gene therapy programs into and through the clinic. \nJoin us to leverage essential insights from over 300 peers from leading biopharma companies with direct experience in driving gene therapies through the clinic and into the market. Keep your finger on the pulse\, form connections with top decision-makers\, and address your specific clinical\, manufacturing\, regulatory\, and commercial bottlenecks to safeguard against costly delays and progress your gene therapies through the pipeline quickly and safely. \nTo know more visit: https://ter.li/x4qqur
URL:http://www.pharmajournalist.com/event/7th-gene-therapy-for-rare-disorders-summit/
LOCATION:The Westin Copley Place\, 10 Huntington Avenue\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR